Back to search
FDAFDA · Food and drugs·Recall number D-0103-2018

RHINO 7 Platinum 5000, capsule, Proprietary Material: 750mg, 1-capsule packets, distributed by Fifty Shades Bayside, NY 11361, UPC 617135861224

Published December 13, 2017 · Recall initiated: September 15, 2017

Summary

FDA records drug Class I recall D-0103-2018, published December 13, 2017 and initiated September 15, 2017. Recalling firm: Gadget Island, Inc; Status: Terminated; Reported quantity: 925 1-capsule packets; Lot: All Lots. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Marketed without an Approved NDA/ANDA: undeclared Active Pharmaceutical Ingredients sildenafil, desmethyl carbodenafil and tadalafil.

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Gadget Island, Inc
Distributor
Nationwide in the USA
UPC
617135861224
Lot
All Lots
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was RHINO 7 Platinum 5000, capsule, Proprietary Material: 750mg, 1-capsule packets, distributed by Fifty Shades Bayside, NY 11361, UPC 617135861224 recalled?

Yes. FDA published recall D-0103-2018 on December 13, 2017. Reported hazard: Marketed without an Approved NDA/ANDA: undeclared Active Pharmaceutical Ingredients sildenafil, desmethyl carbodenafil and tadalafil.

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail

How do I know if my unit is part of the recall?

Compare your product details with the notice. UPC: 617135861224.